November 7, 2018 | Loke Yew Hall, The University of Hong Kong, Pokfulam, Hong Kong

臨床試驗二十載 官產學研聚人才Two Decades of Clinical Trials: Convergence of Talents

Harbour BioMed

Gold Sponsor

Company Profile

Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases. The company's discovery and development programs are centered around its two patented transgenic mouse platforms generating fully human monoclonal antibodies.